Modulus Therapeutics
This company is dedicated to using machine learning to design cell therapies to treat more diseases and patients than ever before.
Launch date
Employees
Market cap
-
Enterprise valuation
€13—19m (Dealroom.co estimates Jul 2021.)
Seattle Washington (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$3.5m | Seed | ||
* | N/A | Acquisition | |
Total Funding | €3.2m |
Related Content
Recent News about Modulus Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.